Status:
ACTIVE_NOT_RECRUITING
Gamification and Medication Adherence (GAME Adherence)
Lead Sponsor:
University of Pennsylvania
Conditions:
Hypertension and Hyperlipidemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A two-arm randomized controlled trial to evaluate whether a gamification intervention plus involvement of a supportive partner (social support) and sending reports to physicians (accountability) incre...
Detailed Description
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality in the United States. Hypertension and hyperlipidemia have been recognized as risk factors for ASCVD for ...
Eligibility Criteria
Inclusion
- Prescribed 1 or 2 blood pressure medications and a statin medication for \> 1 year
- Has supply of medications at the time of enrollment
- Medication possession ratio 40-80% for at least one of those medications for the past 6 months
- Systolic blood pressure \> 140 mm Hg at most recent check
- Owns a smartphone or tablet operating the iOS or Android operating system
Exclusion
- Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension of English)
- Systolic blood pressure \> 180 mm Hg at their last bp check
- Anticipated life expectancy less than 6 months
- Any other reason why it is not feasible to complete the entire study
Key Trial Info
Start Date :
September 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05326386
Start Date
September 12 2022
End Date
May 1 2026
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104